intismeran autogene (mRNA-4157) - Merck (MSD), Moderna
diazoxide (ATH-012) - Neurotec Pharma, Advancell
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT06961006
 
Jun 13, 2025
 
Next